CRIS Current Research Information System

ROMANIELLO, DONATELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.690
NA - Nord America 1.956
EU - Europa 1.750
SA - Sud America 195
Continente sconosciuto - Info sul continente non disponibili 179
AF - Africa 60
OC - Oceania 3
Totale 6.833
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.901
IT - Italia 974
SG - Singapore 747
VN - Vietnam 747
CN - Cina 649
DE - Germania 160
BR - Brasile 158
HK - Hong Kong 156
FR - Francia 98
KR - Corea 92
IE - Irlanda 89
GB - Regno Unito 84
NL - Olanda 68
BD - Bangladesh 64
JP - Giappone 59
SE - Svezia 59
FI - Finlandia 54
IN - India 43
RU - Federazione Russa 41
AT - Austria 32
CA - Canada 25
ES - Italia 24
AR - Argentina 21
CI - Costa d'Avorio 21
ID - Indonesia 20
TH - Thailandia 15
PL - Polonia 13
BG - Bulgaria 12
CH - Svizzera 12
PH - Filippine 12
SC - Seychelles 12
TW - Taiwan 12
IQ - Iraq 11
MX - Messico 11
JO - Giordania 10
PK - Pakistan 9
DK - Danimarca 8
TG - Togo 8
ZA - Sudafrica 8
EC - Ecuador 7
SA - Arabia Saudita 7
TR - Turchia 7
IR - Iran 6
BE - Belgio 5
CR - Costa Rica 5
MY - Malesia 5
MA - Marocco 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
GR - Grecia 3
JM - Giamaica 3
PY - Paraguay 3
RO - Romania 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
IL - Israele 2
LB - Libano 2
LT - Lituania 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
CL - Cile 1
CO - Colombia 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EG - Egitto 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
LU - Lussemburgo 1
LY - Libia 1
ML - Mali 1
NI - Nicaragua 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 6.655
Salva come PNG Salva come JPEG
Città #
Singapore 490
Bologna 420
Ashburn 218
San Jose 200
Hefei 197
Ho Chi Minh City 195
Hanoi 189
Hong Kong 146
Santa Clara 140
Chandler 112
Council Bluffs 91
Dublin 86
Seoul 83
Boardman 82
Beijing 79
Princeton 70
Lauterbourg 66
Dallas 56
Milan 53
Los Angeles 49
Tokyo 44
Bar Harbor 42
Berlin 39
Helsinki 36
New York 36
Southend 36
Modena 34
São Paulo 34
Da Nang 32
Fairfield 32
Munich 28
Rome 28
Buffalo 26
Vienna 25
Amsterdam 22
Frankfurt am Main 22
London 22
Medford 22
Abidjan 21
Guangzhou 20
Seattle 20
Chicago 19
Haiphong 19
San Lazzaro di Savena 19
Nuremberg 18
Bengaluru 17
Redondo Beach 17
Brescia 14
Houston 14
Naples 14
Shanghai 14
Florence 13
Jakarta 13
The Dalles 13
Brooklyn 12
Ninh Bình 12
Sofia 12
Lappeenranta 11
Orem 11
San Diego 11
Amman 10
Can Tho 10
Hải Dương 10
Phoenix 10
Vũng Tàu 10
Woodbridge 10
Bern 9
Bremen 9
Olalla 9
Cambridge 8
Düsseldorf 8
Forlì 8
Jinan 8
Lomé 8
Marcon 8
Reggio Emilia 8
Rimini 8
Warsaw 8
Boydton 7
Bắc Giang 7
Falkenstein 7
Redmond 7
Stanford 7
Thái Nguyên 7
Turin 7
Wilmington 7
Xi'an 7
Bangkok 6
Montreal 6
Toronto 6
Turku 6
Alicante 5
Atlanta 5
Benidorm 5
Chengdu 5
Ferrara 5
Ha Long 5
Long An 5
Madrid 5
Palermo 5
Totale 4.207
Salva come PNG Salva come JPEG
Nome #
BMP7 promotes cardiomyocyte regeneration in zebrafish and adult mice 314
The natural sesquiterpene β- caryophyllene acts as an enviromental decontaminant through the interference with the STAT3 signalling pathway 255
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression 241
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy 226
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies 224
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib 219
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation 212
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 211
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 207
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization 206
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies 200
CEA Cell Adhesion Molecule 6 (CEACAM6), Collagen Type I Alpha 2 Chain (COL1A2), Galectin 4 (LGALS4) and Tetraspanin 8 (TSPAN8) mRNAs as blood biomarkers for colorectal cancer 198
PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systems 192
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells 177
Beyond EGFR inhibition in head and neck squamous cell carcinoma: Overcoming resistance mechanisms and novel therapeutic frontiers 153
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 145
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 142
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 136
Senescence-associated reprogramming impairs response to EGFR neutralization 129
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 125
CIRCADIAN DEPENDENT MOTILITY: THE ROLE FOR THE PERINUCLEAR ACTIN CAP 107
β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells 107
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 102
Targeting anaplastic lymphoma kinase in consensus molecular subtype 1 colon cancer patients 96
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 95
Activation of ALK Signaling Pathway Induces DNA Damage Response in Colorectal Cancer 94
Developing Comprehensive In Vitro and In Vivo Models: Patient-Derived Organoids (PDOs) and Xenografts (PDXs) for Morphological and Functional Analysis and Drug Screening in Head and Neck Squamous Cell Carcinoma 89
Synergy Between Kinase Inhibitors And Antibodies Enables Upfront Prevention Of Recurring Secondary Resistance In Egfr-Mutated Lung Cancer 86
First-line therapy based on kinase inhibitors and antibodies prevents resistance in egfr-mutated lung cancer. 86
Development of Head and Neck Squamous Cell Carcinoma Patient-Derived Xenografts (PDXs) and Organoids (PDXOs) for Morphological Analysis and Drug Screening 85
Senescence-associated reprogramming impairs response to EGFR neutralization 85
β-Hexachlorocyclohexane Drives Carcinogenesis in the Human Normal Bronchial Epithelium Cell Line BEAS-2B 83
Strategies to Overcome Resistance to Osimertinib in EGFR-Mutated Lung Cancer 82
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target Therapy 79
Cancer Immunotherapy: The Dawn of Antibody Cocktails 79
Comparative analysis of the interaction between different flavonoids and pdia3 79
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor 79
JAK2-Regulation Of HER2 “Addiction” In HER2-Positive Breast Cancer Cell Lines 76
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors 74
Biochemical characterization of the ERp57-STAT3 complex 74
STAT3 post-translational modifications drive cellular signaling pathways in prostate cancer cells 68
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models 65
Analysis of stat3 post-translational modifications (ptms) in human prostate cancer with different gleason scores 64
STAT3--ERp57 Interplay in human prostate cancer 63
Dangerous liaison: organochlorine substances, energy metabolism and cancer 63
A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways 61
Circadian dependent motility: the role for the perinuclear actin cap 61
Acetylation and phosphorylation of STAT3 are involved in the responsiveness of microglia to beta amyloid 60
Functional Studies Of Stat3 And Its Interactors In Breast Cancer 58
Interaction between flavonoids and PDIA3 58
EGFR/STAT3/ERp57 Interplay in human prostate cancer progression 57
Protease, an Advance Therapeutic Target in Cancer 56
PARP-1 as coactivator of STAT3 in M14 melanoma cell line 52
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 50
STAT3/ERP57/TPX2 axis and process of “androgen escape” in prostate cancer 50
STAT3's role in microglial cells 50
STAT3-EGFR PATHWAY IN NEUROENDOCRINE PROSTATE CANCER: A CASE REPORT 48
null 46
The ERBB Family of Receptor Tyrosine Kinases: Key Players in Cancer 45
null 39
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy 34
The therapeutic exploitation of IL-1 in cancer: Controlling tumor progression and resistance to targeted therapies 24
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies 8
null 4
Totale 6.833
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.334
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022294 0 3 0 0 3 3 1 35 42 15 118 74
2022/2023624 53 58 24 55 70 50 16 59 124 10 54 51
2023/2024366 44 42 36 30 22 63 14 27 14 28 16 30
2024/20251.514 33 181 131 94 207 93 171 72 72 113 114 233
2025/20263.599 411 362 299 235 282 217 323 191 661 241 214 163
2026/2027336 216 120 0 0 0 0 0 0 0 0 0 0
Totale 6.833